Pentazocine and naloxone
Active substance: PENTAZOCINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE
TABLET · PENTAZOCINE HYDROCHLORIDE 50 mg/1, NALOXONE HYDROCHLORIDE .5 mg/1
United StatesActive
Marketing holder: Actavis Pharma, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- PENTAZOCINE HYDROCHLORIDE · 50 mg/1
- NALOXONE HYDROCHLORIDE · .5 mg/1
Registration
- Registration number
- 0591-0395
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
Sources
- product · openFDA NDC · 0591-0395 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0591-0395 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0591-0395 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0591-0395 · Verified 2026-10-09 · open in source